Literature DB >> 3360957

Monoclonal antibodies to human factor VII: a one step immunoradiometric assay for VII:Ag.

T Takase1, E G Tuddenham, S Chand, A H Goodall.   

Abstract

Three mouse monoclonal antibodies (RFF-VII/1, RFF-VII/2, and RFF-VII/3) which bind specifically to different epitopes on human factor VII antigen were raised. Two of the antibodies, RFF-VII/1 and RFF-VII/2, bound strongly to factor VII antigen (VII:Ag), but only RFF-VII/1 and RFF-VII/3 were potent inhibitors of factor VII coagulation activity (VII:C). RFF-VII/1 and RFF-VII/2 were used in a one step, double monoclonal immunoradiometric assay for VII:Ag. This was highly reproducible and detected as little as 0.05U/dl VII:Ag. Values for VII:Ag obtained for plasma samples from normal subjects (n = 20), patients with liver disease (n = 20), patients treated with warfarin (n = 20), and those congenitally deficient in factor VII (n = 7) correlated very well (r = 0.96) with data obtained in a radioimmunoassay using polyclonal rabbit antiserum to factor VII. This simple and sensitive monoclonal antibody based assay offers a convenient method for the detection of VII:Ag in various disease states.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3360957      PMCID: PMC1141436          DOI: 10.1136/jcp.41.3.337

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  17 in total

1.  Monoclonal antibodies to human factor VII: production of immunodepleted plasma for VII:C assays.

Authors:  T Takase; E G Tuddenham; S Chand; A H Goodall
Journal:  J Clin Pathol       Date:  1988-03       Impact factor: 3.411

2.  Factor VII verona coagulation disorder: double heterozygosis with an abnormal factor VII and heterozygous factor VII deficiency.

Authors:  A Girolami; G Falezza; G Patrassi; M Stenico; L Vettore
Journal:  Blood       Date:  1977-10       Impact factor: 22.113

3.  Preparation of factor IX deficient human plasma by immunoaffinity chromatography using a monoclonal antibody.

Authors:  A H Goodall; G Kemble; D P O'Brien; E Rawlings; F Rotblat; G C Russell; G Janossy; E G Tuddenham
Journal:  Blood       Date:  1982-03       Impact factor: 22.113

4.  Factor VII Padua: a congenital coagulation disorder due to an abnormal factor VII with a peculiar activation pattern.

Authors:  A Girolami; F Fabris; R Dal Bo Zanon; G Ghiotto; A Burul
Journal:  J Lab Clin Med       Date:  1978-03

5.  Factor VII activity and cross reacting material in normal individuals.

Authors:  M G Mazzucconi; M Orlando; H J Hassan; D Romoli; G Mariani
Journal:  Thromb Res       Date:  1979-01       Impact factor: 3.944

6.  Active and inactive factor VII in Dubin-Johnson syndrome with factor-VII deficiency, hereditary factor-VII deficiency and on coumadin administration.

Authors:  M Levanon; S Rimon; M Shani; B Ramot; E Goldberg
Journal:  Br J Haematol       Date:  1972-12       Impact factor: 6.998

7.  Factor VII Padua 2: another factor VII abnormality with defective ox brain thromboplastin activation and a complex hereditary pattern.

Authors:  A Girolami; G Cattarozzi; R Dal Bo Zanon; F Toffanin
Journal:  Blood       Date:  1979-07       Impact factor: 22.113

8.  Molecular variant of factor VII.

Authors:  E Briët; E A Loeliger; N H Van Tilburg; J J Veltkamp
Journal:  Thromb Haemost       Date:  1976-04-30       Impact factor: 5.249

9.  Activation of human factor VII in plasma and in purified systems: roles of activated factor IX, kallikrein, and activated factor XII.

Authors:  U Seligsohn; B Osterud; S F Brown; J H Griffin; S I Rapaport
Journal:  J Clin Invest       Date:  1979-10       Impact factor: 14.808

10.  Isolation and characterization of human factor VII. Activation of factor VII by factor Xa.

Authors:  S P Bajaj; S I Rapaport; S F Brown
Journal:  J Biol Chem       Date:  1981-01-10       Impact factor: 5.157

View more
  1 in total

1.  Monoclonal antibodies to human factor VII: production of immunodepleted plasma for VII:C assays.

Authors:  T Takase; E G Tuddenham; S Chand; A H Goodall
Journal:  J Clin Pathol       Date:  1988-03       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.